Laureate Education, Inc. LAUR 深 沪
等待开盘 04-01 09:30:00 美东时间
34.84
+0.930
+2.74%
华盛通- 最 高34.95
- 今 开34.25
- 成交量 158.45万股
- 最 低 33.72
- 昨 收 33.91
- 总市值 49.82亿
- 52周最高 37.91
- 市盈率 静 18.39
- 换手率 1.11%
- 52周最低 18.56
- 委 比 80.59%
- 总股本 1.43亿
- 历史最高 37.91
- 量 比 1.23
- 振 幅 3.63%
- 历史最低 5.92
- 每 手 1
- 风险率 5.14%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 大摩、高盛上调Denali Therapeutics目标价；Chewy、沛齐遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Atossa Therapeutics"买入"评级，目标价从7美元升至25美元；Needham：维持Nkarta"买入"评级，目标价从10美元升至11美元
03-27 10:22
Laureate Education Announces Date of First Quarter 2026 Earnings Release and Conference Call
Laureate Education, Inc. plans to release its first quarter 2026 results on April 30, 2026, before the market opens. A conference call with investors and analysts will follow at 8:30 a.m. ET to discuss the results and business outlook. Interested parties can register for the call here to receive dial-in information. The webcast, including replays, along with the earnings release and slides, will be available on the Investor Relations section of t...
03-24 20:15
美股大行评级 | 甲骨文绩后分歧大！小摩上调评级至"超配"，目标价缺降至210美元；科尔士百货、AVAV、Blend Labs、Domo遭多家大行下调评级
今日重点评级关注：LUCID CAPITAL MARKETS：上调INmune Bio评级至"买入" 目标价从2美元升至9美元；Clear Street：维持MoonLake Immunotherapeutics Class A"买入"评级，目标价从45美元升至70美元
03-12 12:34
JP Morgan Maintains Overweight on Laureate Education, Raises Price Target to $41.5
JP Morgan analyst Marcelo Santos maintains Laureate Education (NASDAQ:LAUR) with a Overweight and raises the price target from $40 to $41.5.
03-12 03:23
美股大行评级 | 潜在涨幅243.25%！泰利克斯制药获花旗升目标价至22.5美元，维持"买入"评级
今日重点评级关注：花旗：维持Telix Pharmaceuticals"买入"评级，目标价从22美元升至22.5美元；摩根士丹利：维持Vir Biotechnology"超配"评级，目标价从20美元升至24美元
02-25 11:03
美股大行评级 | 大摩将康宁目标价从103美元升至127美元；潜在涨幅1779.7%！IGC Pharma获Ascendiant Capital升目标价至5美元
今日重点评级关注：Ascendiant Capital：维持IGC Pharma"买入"评级，目标价从4.75美元升至5美元；Brookline Capital：维持C4 Therapeutics"买入"评级，目标价从20美元升至30美元
02-24 10:27
快讯 | Laureate Education Inc：BMO将目标价从$36上调至$40
Laureate Education Inc : BMO Raises Target Price to $40 From $36
02-23 19:54
财报速睇 | Laureate Education, Inc. 2025财年Q4营收5.41亿美元，同比增长27.9%；归母净利润1.72亿美元，同比增长83.3%
华盛资讯2月19日讯，Laureate Education, Inc.公布2025财年Q4业绩，公司Q4营收5.41亿美元，同比增长27.9%，归母净利润1.72亿美元，同比增长83.3%。
02-19 20:32
Laureate Education Sees FY2026 Adj EPS $1.95-$2.03 vs $2.14 Est; Sees Sales $1.890B-$1.905B vs $1.851B Est
Laureate Education (NASDAQ:LAUR) is looking for FY2026 Adj EPS of $1.95-$2.03 vs $2.14 analyst estimate. sees sales of $1.890 billion-$1.905 billion vs $1.851 billion analyst estimate.
02-19 20:25
Laureate Education Q4 EPS $1.17 Beats $0.78 Estimate, Sales $541.400M Beat $528.300M Estimate
Laureate Education (NASDAQ:LAUR) reported quarterly earnings of $1.17 per share which beat the analyst consensus estimate of $0.78 by 50.97 percent. This is a 88.71 percent increase over earnings of $0.62 per share from
02-19 20:23
